Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
71 participants
OBSERVATIONAL
2021-01-09
2022-03-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question it aims to answer is:
\- Is bioimpedance-determined fluid status associated with kidney function decline in patients with chronic kidney disease stage 3 - 5 (non dialysis).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pulse Wave Analysis and Velocity in Patients With Chronic Renal Failure: a Cross-sectional Observational Study to Assess Association With Left Ventricular Hypertrophy, Uremic Toxins and Inflammation.
NCT01579032
Body Fluid Dynamics in Hemodialysis Patients, an Estimation of Dry Weight
NCT02325908
Non-invasive Assessment to Predict Tolerance to Fluid Removal on Intermittent Kidney Replacement Therapy
NCT05270759
Biomarkers of Cardiovascular Complications in Chronic Kidney Disease
NCT03274921
Evaluation of Total Blood Volume Measurement During Dialysis on the Incidence of Intradialytic Hypotension
NCT05872984
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During a follow up of one year, 3 or 4 visits will be scheduled.
* Bioimpedance and blood pressure measurements will be achieved by non-invasive techniques.
* Blood sampling will as much as possible coincide with regular blood samplings for clinical purposes.
* All subjects will undergo echocardiography at baseline and after one year follow up.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 18 years
* Signed informed consent
Exclusion Criteria
* estimated glomerular filtration rate \< 20ml/min directly post-nephrectomy
* Clinical conditions affecting bioimpedance measurements: limb amputation, impaired skin integrity, brain stimulator, pacemaker with low threshold or unipolar pacemaker.
* Clinical conditions affecting body composition: liver cirrhosis, active infectious disease or any acute cardiovascular event (defined as cerebrovascular event, myocard infarction, heart failure) during the 3 months before screening for inclusion
* Pregnancy
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ziekenhuis Oost-Limburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pieter Vandervoort, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hasselt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medicine and Life science
Hasselt, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ctu2019039
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.